Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

Por Lavoie Smith, Ellen M., Barton, Debra L., Qin, Rui, Steen, Preston D., Aaronson, Neil K., Loprinzi, Charles L.
Publicado no Qual Life Res (2013)

A phase II trial of the Src-kinase inhibitor saracatinib after 4 cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621

Por Molina, Julian R., Foster, Nathan R., Reungwetwattana, Thanyanan, Nelson, Garth D., Grainger, Andrew V., Steen, Preston D., Stella, Philip J., Marks, Randolph, Wright, John, Adjei, Alex A.
Publicado no Lung Cancer (2014)

Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial

Por Holtan, Shernan G., Steen, Preston D., Foster, Nathan R., Erlichman, Charles, Medeiros, Fabiola, Ames, Matthew M., Safgren, Stephanie L., Graham, David L., Behrens, Robert J., Goetz, Matthew P.
Publicado em 2012

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N0326()...

Por Dy, Grace K., Hillman, Shauna L., Rowland, Kendrith M., Molina, Julian R., Steen, Preston D., Wender, Donald B., Nair, Suresh, Mandrekar, Sumithra, Schild, Steven E., Adjei, Alex A.
Publicado no Cancer (2010)

Phase 2 Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive-Stage Small Cell Lung Cancer, N0423

Por Chee, Cheng E., Jett, James R., Bernath, Albert M., Foster, Nathan R., Nelson, Garth D., Molina, Julian, Nikcevich, Daniel A., Steen, Preston D., Flynn, Patrick J., Rowland, Kendrith M.
Publicado no Cancer (2010)

Hepatic Arterial Infusion and Systemic Chemotherapy after Multiple Metastasectomy in Patients with Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer Treatment Gr...

Por Bolton, John S., O’Connell, Michael J., Mahoney, Michelle R., Farr, Gist H., Fitch, Tom R., Maples, William J., Nagorney, David M., Rubin, Joseph, Fuloria, Jyotsna, Steen, Preston D., Alberts, Steven R.
Publicado em 2011

A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes():NCCTG N08C7

Por Pruthi, Sandhya, Qin, Rui, Terstreip, Shelby A., Liu, Heshan, Loprinzi, Charles L., Shah, Tushar R. C., Tucker, Kenneth F., Dakhil, Shaker R., Bury, Martin J., Carolla, Robert L., Steen, Preston D., Vuky, Jacqueline, Barton, Debra L.
Publicado em 2012

Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program

Por Bleeker, Jonathan S., Sumey, Christopher J., Powell, Steven F., Steen, Preston D., Keppen, Michael D., Lohr, Michele, Thambi-Pillai, Thavam, Kurniali, Peter, Mazurczak, Miroslaw, Gitau, Mark M., Blanchard, Miran J., Nowak, Ryan K., McGraw, Steven, Sticca, Robert, Tuvin, Daniel, Timmerman, Gary
Publicado no Surg Open Sci (2020)

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second- or third-line treatment of patients with EGFR wild-type advanced non-small cell lung cancer (ECOG-ACRIN 1512): a...

Por Neal, Joel W., Dahlberg, Suzanne E., Wakelee, Heather A., Aisner, Seena C., Bowden, Michaela, Huang, Ying, Carbone, David P., Gerstner, Gregory J., Lerner, Rachel E., Rubin, Jerome L., Owonikoko, Taofeek K., Stella, Philip J., Steen, Preston D., Khalid, Ahmed Ali, Ramalingam, Suresh S.
Publicado no Lancet Oncol (2016)